# Cerecor Inc.

**Canonical:** https://apis.io/providers/cerecor-inc/  
**Website:** https://www.avalotx.com  
**APIs profiled:** 0

Cerecor Inc., now operating as Avalo Therapeutics, is a clinical-stage biotechnology company focused on developing novel IL-1β pathway inhibitors for immune-mediated inflammatory diseases. The company advances candidates such as abdakibart (AVTX-009) for hidradenitis suppurativa and AVTX-010, a long‑acting anti‑IL‑β monoclonal antibody, aiming to address unmet medical needs through innovative therapeutics.

## Kin Score — 6.3 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 48.2 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 7.8 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Cerecor Inc Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Therapeutics, IL-1β, Clinical-stage

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/cerecor-inc/). Scores are computed from the provider's own public artifacts under a published rubric.